DB
PLSE icon

Dmitry Balyasny’s Pulse Biosciences PLSE Stock Holding History

Dmitry Balyasny’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9M Buy
718,103
+452,939
+171% +$10.7M 0.02% 714
2026
Q1 		$5.72M Buy
+265,164
New +$4.89M 0.01% 1308

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dmitry Balyasny's PLSE Position: Q2 2026 in Review

Dmitry Balyasny increased its Pulse Biosciences (PLSE) stake by 171% in Q2 2026, buying an estimated $10.7M and bringing the position to 718,103 shares worth $19.9M. The position accounts for 0.02% of the portfolio, ranked #714.

Dmitry Balyasny first reported a position in PLSE in Q1 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Dmitry Balyasny held 718,103 shares of Pulse Biosciences worth $19.9M as of Q2 2026.
  • Dmitry Balyasny bought 452,939 Pulse Biosciences shares in Q2 2026, an estimated $10.7M.
  • Pulse Biosciences made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #714 holding.
  • Dmitry Balyasny first reported a position in Pulse Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.